首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2020年 8期“胰腺疾病的内镜诊疗” => 肝脏肿瘤 =>血清外泌体来源的mi..
血清外泌体来源的microRNA-221-3p在肝细胞癌中的表达及意义
Expression and clinical significance of serum exosomal microRNA-221-3p in hepatocellular carcinoma
文章发布日期:2020年07月09日  来源:  作者:吴俊艺,赖智德,田毅峰,等  点击次数:652次  下载次数:45次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的 探讨肝细胞癌(HCC)患者血清外泌体来源 microRNA(miRNA)-221-3p的表达水平及分析其临床意义。方法 选取2010年2月-2014年12月南京大学医学院附属南京鼓楼医院经手术治疗后诊断为HCC的66例患者作为HCC组,选取25例同期在本院接受健康检查的体检者作为对照组。通过外泌体提取试剂盒分离HCC组和对照组血清中的外泌体,采用蛋白免疫印迹检测外泌体标记蛋白分子,透射电镜鉴定血清外泌体形态;实时荧光定量PCR方法检测两组血清外泌体来源的miRNA-221-3p表达水平。计量资料两组间比较采用Mann-Whitney U检验,计数资料两组间比较采用χ2 检验。采用Kaplan-Meier方法及log-rank检验分析血清外泌体来源的miRNA-221-3p表达与预后关系,采用 Cox 比例风险回归模型分析预后影响因素。结果 血清来源的外泌体是直径为40~100 nm囊泡体,表达HSP70、Alix及CD63。HCC组血清来源外泌体中miRNA-221-3p较对照组表达水平升高,差异具有统计学意义(U=354.00,P<0.001)。 HCC患者血清外泌体miRNA-221-3p高表达与肿瘤大小(χ2= 6.016,P=0.014)、包膜侵犯(χ2=7.580,P=0.006)和TNM分期(χ2=6.340,P=0.012)有关。此外,血清外泌体来源的miRNA-221-3p表达水平较高的HCC患者总体生存率较低,差异具有统计学意义(χ2=17.105,P<0.001)。多因素分析结果表明血清外泌体来源的miRNA-221-3p表达水平(风险比=2.434,95%可信区间: 1.178~5.027,P=0.016)及肿瘤分期(风险比=2.653,95%可信区间: 1.222~5.760,P=0.014)是影响HCC患者预后的独立危险因素。 结论 HCC患者血清外泌体来源的miRNA-221-3p表达水平明显升高,对HCC诊断及预后判断具有参考价值。
【Abstract】:Objective To investigate the expression and clinical significance of serum exosomal microRNA(miRNA)-221-3p in hepatocellular carcinoma (HCC). Methods A total of 66 patients who underwent surgery in Nanjing Drum Tower Hospital, Nanjing University Medical School, from February 2010 to December 2014 and were diagnosed with HCC were enrolled as HCC group, and 25 individuals who underwent physical examination in our hospital during the same period of time were enrolled as control group. The exosome extraction kit was used to isolate the exosomes in serum; Western blotting was used to measure the expression of exosome markers; a transmission electron microscope was used to observe the morphology of serum exosomes; quantitative real-time PCR was used to measure the expression of serum exosomal miRNA-221-3p. The Mann-Whitney U test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups. The Kaplan-Meier method and the log-rank test were used to analyze the association of the expression of serum exosomal miRNA-221-3p with prognosis, and the Cox proportional hazards regression model was used to analyze the influencing factors for prognosis. Results Serum exosomes were small membranous vesicles with a diameter of about 40-100 nm, and HSP70, Alix, and CD63 were expressed in the exosomes. The HCC group had significantly higher expression of serum exosomal miRNA-221-3p than the control group (U=354.00, P<0.001). In the patients with HCC, the high expression of serum exosomal miRNA-221-3p was associated with tumor size (χ2=6.016, P=0.014), capsular invasion (χ2=7.580, P=0.006), and TNM stage (χ2=6.340, P=0.012). In addition, the HCC patients with high expression of serum exosomal miRNA-221-3p had a significantly lower overall survival rate than those with low expression (χ2=17.105, P<0.001). The multivariate analysis showed that the expression of serum exosomal miRNA-221-3p (hazard ratio [HR]=2.434, 95% confidence interval [CI]: 1.178-5.027, P=0.016) and tumor stage (HR=2.653, 95% CI: 1.222-5.760, P=0.014) were independent risk factors for the prognosis of patients with HCC. Conclusion There is a significant increase in the expression of serum exosomal miRNA-221-3p in HCC patients, which provides a reference for the diagnosis and prognostic evaluation of HCC.
【关键字】:癌,肝细胞; 外泌体; 微RNAs; 预后
【Key words】:carcinoma,hepatocellular; exosomes; microRNAs; prognosis
【引证本文】:WU JY, LAI ZD, TIAN YF, et al. Expression and clinical significance of serum exosomal microRNA-221-3p in hepatocellular carcinoma[J]. J Clin Hepatol, 2020, 36(8): 1768-1772. (in Chinese)
吴俊艺, 赖智德, 田毅峰, 等. 血清外泌体来源的microRNA-221-3p在肝细胞癌中的表达及意义[J]. 临床肝胆病杂志, 2020, 36(8): 1768-1772.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号